Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-11 Sale | 2026-03-13 5:28 pm | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 4,772 | $74.91 | $357,471 | 38,730 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 5:28 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 3,162 | $71.64 | $226,526 | 91,309 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 5:28 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 500 | $72.62 | $36,310 | 79,390 (Direct) | View |
| 2026-03-06 Sale | 2026-03-10 4:09 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 5,723 | $74.19 | $424,617 | 94,471 (Direct) | View |
| 2026-03-06 Sale | 2026-03-10 4:06 pm | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 6,572 | $74.33 | $488,474 | 51,946 (Direct) | View |
| 2026-03-05 Sale | 2026-03-05 5:46 pm | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 7,312 | $75.5 | $552,031 | 195,481 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 6:46 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 417 | $74 | $30,858 | 103,508 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 6:45 pm | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 2,060 | $76.5 | $157,590 | 84,782 (Direct) | View |
| 2026-03-03 Sale | 2026-03-03 6:01 pm | ANI PHARMACEUTICALS INC | ANIP | Walsh Patrick D Director | 6,000 | $74.23 | $445,380 | 52,405 (Direct) | View |
| 2026-02-20 Sale | 2026-02-23 5:31 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 5,323 | $78.02 | $415,300 | 84,840 (Direct) | View |
| 2026-02-19 Sale | 2026-02-23 5:31 pm | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 3,814 | $77.74 | $296,495 | 49,263 (Direct) | View |
| 2026-02-12 Sale | 2026-02-17 4:08 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 7,032 | $76.55 | $538,300 | 90,163 (Direct) | View |
| 2026-02-13 Sale | 2026-02-17 4:04 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 500 | $76.8 | $38,400 | 67,550 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-07 Tax Withholding | 2026-03-10 4:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 3,314 | $74.04 | 94,471 (Direct) | View |
| 2026-03-07 Tax Withholding | 2026-03-10 4:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 17,060 | $74.04 | 404,889 (Direct) | View |
| 2026-03-07 Tax Withholding | 2026-03-10 4:07 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 3,314 | $74.04 | 81,468 (Direct) | View |
| 2026-03-07 Tax Withholding | 2026-03-10 4:04 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 5,150 | $74.04 | 180,393 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-05 5:46 pm | N/A 2027-03-30 | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 3,312 | $49.51 | 195,481 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 11,116 | $77.15 | 537,976 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 628 | $73.9 | 43,502 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 6,021 | $77.15 | 43,502 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,221 | $73.9 | 103,925 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 21,306 | $77.15 | 103,925 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 12,217 | $73.9 | 421,949 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 75,592 | $77.15 | 421,949 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 2,221 | $73.9 | 86,842 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 12,969 | $77.15 | 86,842 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 2,221 | $73.9 | 233,406 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:58 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 11,116 | $77.15 | 233,406 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 1,555 | $73.9 | 58,518 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 10,810 | $77.15 | 58,518 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 1,555 | $73.9 | 79,890 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 13,895 | $77.15 | 79,890 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 2,773 | $73.9 | 189,543 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 22,233 | $77.15 | 189,543 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:08 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 485 | $77.36 | 38,109 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:08 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 566 | $76.7 | 38,109 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:08 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,403 | $77.36 | 90,163 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:08 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 3,173 | $76.7 | 90,163 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:07 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 10,298 | $77.36 | 358,574 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:07 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 11,688 | $76.7 | 358,574 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:06 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 1,888 | $77.36 | 76,094 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:06 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 1,775 | $76.7 | 76,094 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:05 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 1,717 | $77.36 | 224,511 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:05 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 1,608 | $76.7 | 224,511 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:05 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 1,290 | $77.36 | 53,077 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:05 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 1,180 | $76.7 | 53,077 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:04 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 1,779 | $77.36 | 67,550 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:04 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 1,534 | $76.7 | 67,550 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-17 4:03 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 2,448 | $77.36 | 170,083 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-17 4:03 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 2,829 | $76.7 | 170,083 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:13 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 5,503 | $76.25 | 175,360 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:13 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 3,011 | $76.25 | 71,363 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 3,017 | $76.25 | 55,547 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 4,269 | $76.25 | 227,836 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:11 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 4,267 | $76.25 | 79,757 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 30,659 | $76.25 | 380,560 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:08 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 4,546 | $76.25 | 102,771 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:07 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 1,762 | $76.25 | 39,160 (Direct) | View |
| 2026-02-11 Tax Withholding | 2026-02-13 4:06 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 2,898 | $76.25 | 526,860 (Direct) | View |